California State Teachers Retirement System (CalSTRS)’s Eterna Therapeutics ERNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2
Closed -$27K 3190
2022
Q1
$27K Hold
2
﹤0.01% 3146
2021
Q4
$67K Hold
2
﹤0.01% 3101
2021
Q3
$149K Sell
2
-2
-50% -$173K ﹤0.01% 2852
2021
Q2
$592K Buy
+4
New +$576K ﹤0.01% 2548

Other funds holding ERNA

California State Teachers Retirement System (CalSTRS)'s ERNA Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Eterna Therapeutics (ERNA) in Q2 2022, closing a stake of 2 shares — an estimated $27K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ERNA in Q2 2021 and held it in 4 quarters. The position peaked at $592K in Q2 2021. 34 funds tracked by Wall St. Rank hold ERNA as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Eterna Therapeutics position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 2 Eterna Therapeutics shares in Q2 2022, an estimated $27K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Eterna Therapeutics in Q2 2021 and held it in 4 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Eterna Therapeutics position peaked at $592K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.